preferred drug
Scope
Date
~
-
Business & Politics
Korail to join Manila railway maintenance project
South Korea's state-run railway company Korea Railroad Corporation (Korail) said on Monday that it participates in the operation and maintenance (O&...
Sep 11, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
IMM consortium picked as preferred bidder for Ecorbit
A consortium of IMM Private Equity and IMM Investment has moved a step closer to owning South Korea’s No. 1 landfill company Ecorbit Co. after...
Aug 26, 2024 (Gmt+09:00)
-
Leadership & Management
Hanwha’s Kim Dong-seon to raise his stake in Galleria to 19.86%
Kim Dong-seon, vice president of South Korea’s Hanwha Galleria Corp. and the third son of Hanwha Group Chairman Kim Seung-yeon, plans to buy a...
Aug 23, 2024 (Gmt+09:00)
-
Bio & Pharma
Yuhan’s lung cancer drug clears FDA hurdle for global debut
A new lung cancer treatment developed by South Korea’s Yuhan Corp. has secured approval from the US Food and Drug Administration (FDA) as a co...
Aug 21, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
Hansae Yes24 moves closer to acquiring GM supplier Erae AMS
Hansae Yes24 Holdings Co., the holding company of South Korea’s leading apparel original equipment manufacturer (OEM) Hansae Co., has moved a ...
Aug 21, 2024 (Gmt+09:00)
-
Bio & Pharma
IMBiologics transfers autoimmune disease drug tech to Huadong Pharma
South Korea's antibody-based biotech company IMBiologics announced on Friday that it signed a contract to transfer the technology of its autoimmune ...
Aug 16, 2024 (Gmt+09:00)
-
Bio & Pharma
Costco sells Celltrion's Yuflyma Low WAC in US
South Korea's Celltrion Inc. announced on Tuesday that its autoimmune disease treatment Yuflyma (Low WAC, active ingredient adalimumab) is now avail...
Aug 13, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
Fashion OEM Hansae bids for GM Korea supplier Erae AMS
The holding company of Hansae Co., a leading global apparel original equipment manufacturer (OEM), is eyeing expansion into auto parts production by...
Aug 13, 2024 (Gmt+09:00)
-
Machinery
Woojin selected as preferred bidder for Inglewood light rail project
Woojin Industrial Systems Co., a South Korean railway vehicle manufacturer, said on Friday that it has been selected as the preferred bidder for the...
Aug 09, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion's Zymfentra joins US insurance-covered drug lists
South Korean biosimilar maker Celltrion Inc. said on Monday that its subcutaneous injection formulation for autoimmune diseases, Zymfentra (inflixim...
Aug 06, 2024 (Gmt+09:00)
-
E-commerce
Qxpress investors to take over Qoo10 founder's control
Financial investors of Qxpress Pte. are set to take over Singapore-based Qoo10 Pte. and its founder Ku Young Bae’s control amid financial turm...
Aug 02, 2024 (Gmt+09:00)
-
Aerospace & Defense
Hanwha Ocean wins $332 mn ship order from S.Korean Navy
South Korea's Hanwha Ocean Co. announced on Thursday that it was selected as the preferred bidder for the second auxiliary oiler replenishment (AOE)...
Jul 26, 2024 (Gmt+09:00)
-
Bio & Pharma
Huonslab eyes speedy anticancer drug delivery with new patent
South Korean biotech Huons Global Co. said on Tuesday that its research and development unit Huonslab has issued a domestic patent claiming a techno...
Jul 23, 2024 (Gmt+09:00)
-
Chemical Industry
Hyosung to sell its specialty gas unit for $943 mn to Korean PEs
South Korea’s Hyosung Group is poised to sell a 100% stake in its specialty and industrial gas unit to a consortium led by IMM Private Equity ...
Jul 12, 2024 (Gmt+09:00)
-
Real estate
Korea’s POBA to invest $109 mn in Koramco’s office REIT
South Korea’s Public Officials Benefit Association (POBA) is set to commit 150 billion won ($108.5 million) in preferred stocks for offices in...
Jul 08, 2024 (Gmt+09:00)
-
Korean startups
Korean IT firms prefer engineers with business capabilities
More South Korean information technology companies are seeking engineers with business capabilities as artificial intelligence is expected to take o...
Jun 17, 2024 (Gmt+09:00)
-
Private equity
Q Capital named K-drama maker Chorokbaem's preferred bidder
Seoul-based private equity firm Q Capital Partners seeks to buy a 39.3% stake with management rights in South Korean drama series producer Chorokbae...
Jun 11, 2024 (Gmt+09:00)
-
Bio & Pharma
SK Biopharm mulls acquiring firms, drug sales rights in US
SAN DIEGO, California -- South Korea’s SK Biopharmaceuticals Co. is considering acquiring firms in the US, or the sales rights to some of thei...
Jun 07, 2024 (Gmt+09:00)
-
Bio & Pharma
Handok gets Biocon's obesity drug exclusive distribution in S.Korea
South Korean pharmaceutical company Handok Inc. announced on Friday that it signed an exclusive domestic sales and distribution agreement with India...
May 24, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion eyes M&A in Europe, $3.3 bn Zymfentra sales: chairman
WASHINGTON, D.C. – South Korean biosimilar giant Celltrion Inc. is accelerating its push to transform into a novel drug developer, going after...
May 23, 2024 (Gmt+09:00)
-
Bio & Pharma
S.Korean anti-obesity drugmakers eye niche demand
The global weight management market has entered a new chapter following the arrival of blockbuster weight-loss medication Wegovy, and South Korean l...
May 07, 2024 (Gmt+09:00)
-
Future mobility
Hyundai to invest $923 million on self-driving JV Motional
Hyundai Motor Group, the world’s third-largest automaker, is set to spend nearly $1 billion on Motional, its loss-making self-driving joint ve...
May 03, 2024 (Gmt+09:00)
-
Bio & Pharma
HK inno.N to release K-CAB in MENA market
South Korean bio-health company HK inno.N announced on Tuesday that it signed a contract with Saudi Arabian local pharmaceutical company Tabuk Pharm...
Apr 23, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
Blackstone signs over $1 bn deal with MBK for 1st exit in Korea
Private equity giant Blackstone Inc. is set to mark its first exit from South Korea by selling a 71.25% stake in the holding firm of Geo-Young Corp....
Apr 22, 2024 (Gmt+09:00)
-
Real estate
Keppel REIT to sell Seoul-based prime office T Tower
Singapore’s Keppel REIT Management Ltd. is set to divest of its Seoul-based prime office building T Tower near Seoul Station.Real estate manag...
Apr 16, 2024 (Gmt+09:00)
-
Bio & Pharma
Samsung begins new drug development for rare diseases
Samsung Bioepis Co., a biosimilar development unit of South Korea’s top conglomerate Samsung Group, has begun its new drug development busines...
Mar 24, 2024 (Gmt+09:00)
-
Bio & Pharma
Drug maker Boryung targets its highest-ever sales in 2024
Boryung Corp., formerly Boryung Pharmaceutical Co., aims to join the 1 trillion won ($748 million) sales club this year, driven by new chronic disea...
Mar 20, 2024 (Gmt+09:00)
-
Energy
Hyundai E&C wins $132 mn biogas facility project
Hyundai Engineering & Construction Co. (Hyundai E&C) announced on Monday that it was selected as the preferred bidder for a private invest...
Mar 19, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion'a autoimmune disease drug Zymfentra makes US debut
South Korean biopharmaceutical giant Celltrion Inc. said on March 17 that it has launched its new autoimmune disease treatment Zymfentra in the US m...
Mar 18, 2024 (Gmt+09:00)
-
Artificial intelligence
LG CNS to develop AI platform of S.Korean government
South Korea’s LG CNS Co., a cloud computing services arm of LG Corp., announced on Sunday that it plans to develop a government-wide hyperscal...
Mar 11, 2024 (Gmt+09:00)
Latest News
- 1 Hyundai, Waymo forge multi-year, strategic partnership for self-driving vehicles
- 2 AI startup MarqVision raises $16.5 mn to close Series A
- 3 Taihan Cable wins $630 mn power grid project in Singapore
- 4 Korean startup scene is gloomy, say 2 out of 5 startup CEOs
- 5 MBK ups stakes for Korea Zinc to match buyback offer